Choose a country below to begin
- WHO Accelerated registration of FPPs approved by SRA
- WHO Collaborative Registration Process: Accelerated Registration of Prequalified FPPs
- WHO Prequalification of Medicines Programme (PQP) – Abridged Assessments
- WHO Prequalification of Medicines Programme (PQP) – Full Assessments
- WHO Collaborative Registration Procedure: Finished Pharmaceutical Products assessed and approved by SRAs
- COVID-19 Technology Access Pool (C-TAP)
- Parallel recommendation and regulatory pathway
- Coordinated Scientific Advice (CSA) for Health Product R&D
- Emergency Use Listing (EUL) Procedure for Vaccines
- WHO Collaborative Registration Process: Accelerated Registration of Prequalified FPPs
- WHO Prequalification of Medicines Programme (PQP) – Abridged Assessments
- WHO Prequalification of Medicines Programme (PQP) – Full Assessments
- WHO Collaborative Registration Procedure: Finished Pharmaceutical Products assessed and approved by SRAs
- COVID-19 Technology Access Pool (C-TAP)
- Parallel recommendation and regulatory pathway
- Coordinated Scientific Advice (CSA) for Health Product R&D
- Emergency Use Listing (EUL) Procedure for Vaccines